The availability of allergen molecules ('components') from several protein families has advanced our understanding of immunoglobulin E (IgE)-mediated responses and enabled 'component-resolved diagnosis' (CRD). The European Academy of Allergy and Clinical Immunology (EAACI) Molecular Allergology User's Guide (MAUG) provides comprehensive information on important allergens and describes the diagnostic options using CRD. Part A of the EAACI MAUG introduces allergen molecules, families, composition of extracts, databases, and diagnostic IgE, skin, and basophil tests. Singleplex and multiplex IgE assays with components improve both sensitivity for low-abundance allergens and analytical specificity; IgE to individual allergens can yield informati...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has adva...
The availability of allergen molecules (‘components’) from several protein families has advanced our...
The availability of allergen molecules (‘components’) from several protein families has advanced our...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has advanced our...
The availability of allergen molecules ('components') from several protein families has adva...
The availability of allergen molecules (‘components’) from several protein families has advanced our...
The availability of allergen molecules (‘components’) from several protein families has advanced our...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowle...